drugset / Trial / NCT00075413

Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer

NCT00075413 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating women with locally advanced or metastatic breast cancer.

Timeline

Start
2002-11
Primary completion
2005-07
Completion
—

Outcome

Outcome not reported

Stopped: “Unable to identify qualified subjects willing to participate in this study”

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule — Intravenous

Indications